Page last updated: 2024-08-23

mifepristone and Osteoporosis, Postmenopausal

mifepristone has been researched along with Osteoporosis, Postmenopausal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barengolts, EI; Lathon, PV; Lindh, FG	1

Other Studies

1 other study(ies) available for mifepristone and Osteoporosis, Postmenopausal

Article	Year
Progesterone antagonist RU 486 has bone-sparing effects in ovariectomized rats. Bone, 1995, Volume: 17, Issue:1 Topics: Analysis of Variance; Animals; Bone Density; Bone Resorption; Drug Interactions; Drug Therapy, Combination; Female; Hormone Antagonists; Humans; Injections, Intramuscular; Injections, Subcutaneous; Medroxyprogesterone; Mifepristone; Osteoporosis, Postmenopausal; Ovariectomy; Progesterone Congeners; Random Allocation; Rats; Rats, Sprague-Dawley; Tibia	1995

Article

Year

Progesterone antagonist RU 486 has bone-sparing effects in ovariectomized rats.

Bone, 1995, Volume: 17, Issue:1

Topics: Analysis of Variance; Animals; Bone Density; Bone Resorption; Drug Interactions; Drug Therapy, Combination; Female; Hormone Antagonists; Humans; Injections, Intramuscular; Injections, Subcutaneous; Medroxyprogesterone; Mifepristone; Osteoporosis, Postmenopausal; Ovariectomy; Progesterone Congeners; Random Allocation; Rats; Rats, Sprague-Dawley; Tibia

1995